Dr. Andrew P. Battiata, MD, MS

Dr. Battiata practices at Charleston ENT Associates in Charleston, South Carolina.

Dr. Battiata's NPI, 1639222037, was assigned on January 19, 2007. Dr. Battiata graduated from Georgetown University School Of Medicine in 2000. Dr. Battiata holds South Carolina license LLTL 32328.

Dr. Battiata's primary practice is Charleston ENT Associates, at 2295 Henry Tecklenburg Dr, Charleston, SC 29414 in Charleston County. The practice phone is (843) 766-6103.

Dr. Battiata's primary practice is Charleston ENT Associates in Charleston, South Carolina. Dr. Battiata is also affiliated with Prisma Health Richland Hospital. The medical group on file is Charleston ENT & Allergy. Dmand AI also links Dr. Battiata to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Battiata practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Battiata's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Battiata is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Battiata's licenses on file in 4 states: South Carolina, Maryland, Virginia and New York.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Battiata treats.

CMS data shows 4,018 Medicare services from Dr. Battiata across 24 procedure codes in 2024, for 693 Medicare patients. Medicare paid $173,189 for them. Every service was in an office.

CMS counts 693 Medicare patients who saw Dr. Battiata in 2024. The largest group is 65 to 74, with 330 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Battiata's median patient age at 56, with 59% women.

In 2024, Dr. Battiata wrote 983 Medicare Part D claims for 356 patients. 94% of them were for generic drugs. CMS names the drug for 819 of them, across 19 drugs with 11 or more claims each, at $66,976 in total drug cost. In 2023, CMS named 702 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Battiata for performance year 2024, reported as part of a group. Dr. Battiata accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Battiata. The most frequent topics are Interleukin-15, Interleukins and Protein Biosynthesis. Dr. Battiata has published most often in Arch Otolaryngol Head Neck Surg. Dr. Battiata's most frequent co-authors are Eric Alan Mair, MD, Carol Faith Adair, MD and John D. Casler, MD.

CMS Open Payments shows 58 general payments to Dr. Battiata from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Stryker Corporation paid the most, $1,579.

Dmand AI lists 1 award for Dr. Battiata, most recently CMS Stage 1 EHR in 2012.

Dr. Battiata graduated from Georgetown University School Of Medicine in 2000.

Dr. Battiata is in network with 11 carriers, including United Healthcare, Cigna and Molina. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.